3 studies on Ghrh r mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**TNBC patients currently have no approved targeted therapy**, making every mechanistically distinct druggable axis clinically meaningful. The finding that `SV1` — not the canonical `GHRH-R` — dominates receptor expre…
These findings suggest a potential therapeutic role for GHRH antagonists in managing aggressive forms of papillary thyroid cancer, particularly those resistant to conventional treatments. The key implication is the se…
These findings suggest a novel therapeutic avenue for optic neuropathies like glaucoma. While both GHRH agonists and antagonists showed some neuroprotective effects, the agonist **MR-409** uniquely synergized with the…